IRCT20190706044111N4招募中未知
A randomized, open label, two treatment, two period, two sequence, single dose, crossover, bioequivalence study of Sitagliptin 50mg tablet of Alborzdarou Pharm Co., IRAN and Januvia 50mg tablet of MSD in 24 healthy adult subjects under fasting condition
Alborzdarou Pharm. Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 50 years（—）
- 性别
- All
入选标准
- •Aged between 20 - 50 years
- •- Body weight between 50 – 100 kg
- •- Having good health on the basis of medical history and physical & clinical examination
- •- Understand the procedures and give written informed consent
排除标准
- •Subject showed clinically relevant deviations from normal in physical examination.
- •Subject had undergone surgery of the gastro-intestinal tract
- •Subject had donated a unit of blood or participated in another clinical trial, within the last tree months before the first treatment.
- •Subject had a history of drug or alcohol abuse.
- •Subject who smokes more than 10 cigarettes per day.
- •Subject had used any prescription medication within 14 days, or any non-prescription medication within 7 days, before the first treatment.
- •Subject had a history of allergic to this class of drugs
研究者
相似试验
已完成
不适用
Study on Leuprolide Acetate depot suspension 7.5 mg of sun pharmaceutical industries Limited in prostate cancer patients to compare the blood levels of test product with that of reference productCTRI/2018/06/014606Sun Pharmaceutical Industries Ltd India21
进行中（未招募）
不适用
Two way crossover steady state pharmacokinetics and bioavailability study of Xykaa 1000 mg Extend release tabletCTRI/2015/01/005468Troikaa Pharmaceuticals Ltd18
已完成
1 期
A clinical trial to study and compare the pharmacokinetic and pharmacodynamic effects of two dry powder inhaler devices, test and reference containing Salmeterol 25mcg and fluticasone propionate 250mcg with salmeterol 50mcg and fluticasone propionate 500mcg in patients with severe asthma.CTRI/2013/08/003878Sun Pharma Advanced Research Company Ltd24
Unknown
Unknown
This is a comparative drug concentration assessment study of Aripiprazole 400 mg Injection in patients with schizophrenia.CTRI/2023/05/052569PLIVA Croatia Ltd
尚未招募
不适用
Comparative study for Imatinib Mesylate 400mg tablets of Sponsor with Imatinib Mesylate 400mg tablets of (Gleevec®)Novartis Pharmaceuticals Corporation, New Jersey in patients with Chronic Myeloid Leukemia and/or Gastrointestinal Stromal Tumor under fed steady-state conditioCTRI/2014/11/005156atco Pharma Limited40